Cha AI Healthcare Co., Ltd. (KRX:025620)
South Korea · Delayed Price · Currency is KRW 5,200.00
+160.00 (3.17%)
Aug 31, 2026, 3:30 PM KST
Cha AI Healthcare Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,435 | 7,305 | 15,675 | 16,089 | 6,246 | 14,978 |
Revenue Growth | -5.37% | -53.40% | -2.57% | 157.58% | -58.30% | -50.92% |
Gross Profit Gross Profit Growth | 2,325 | 2,064 | 7,351 | 7,966 | 904.53 | 716.44 |
Operating Income Operating Income Growth | -8,230 | -7,702 | -6,728 | -9,354 | -7,983 | -18,133 |
Net Income Net Income Growth | 8,144 | 1,367 | -9,493 | -6,797 | -21,435 | -38,564 |
Earnings Per Share EPS Growth | 574.41 | 180.75 | -2122.05 | -1560.23 | -7588.09 | -13187.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Internal Transaction Adjustment Internal Transaction Adjustment Growth | -820.13 | -658.35 | -210.71 | -3.26 | 111.7 | -532.97 |
South Korea South Korea Growth | 7,241 | 6,025 | 13,019 | 14,389 | 5,868 | 15,035 |
China China Growth | 2,014 | 1,939 | 2,867 | 1,704 | 266.05 | 60.53 |
Total Total Growth | 8,435 | 7,305 | 15,675 | 16,089 | 6,246 | 14,978 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,258 | 42,040 | 4,007 | 5,003 | 10,504 | 8,301 |
Total Debt Total Debt Growth | 40,735 | 30,565 | 5,286 | 2,782 | 2,754 | 8,601 |
Net Cash (Debt) Net Cash Growth | -25,478 | 11,475 | -1,279 | 2,221 | 7,750 | -299.74 |
Net Cash Growth | - | - | - | -71.34% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1796.96 | 1517.44 | -285.94 | 509.77 | 2743.53 | -102.50 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -6,006 | -6,712 | -6,913 | -9,861 | -4,982 | -3,490 |
Capital Expenditures CapEx Growth | -119.54 | - | -214.07 | -86.12 | -919.12 | -241.96 |
Free Cash Flow Free Cash Flow Growth | -6,126 | -6,712 | -7,128 | -9,947 | -5,901 | -3,732 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.56% | 28.26% | 46.90% | 49.51% | 14.48% | 4.78% |
Operating Margin | -97.58% | -105.44% | -42.92% | -58.14% | -127.81% | -121.07% |
Pretax Margin | 96.73% | 18.71% | -52.84% | -37.02% | -312.37% | -239.87% |
Profit Margin | 96.55% | 18.71% | -60.56% | -42.24% | -343.16% | -257.48% |
FCF Margin | -72.62% | -91.88% | -45.47% | -61.83% | -94.47% | -24.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.77 | 141.89 | - | - | - | - |
Forward PE | - | 13.42 | 13.42 | 13.42 | 13.42 | 13.42 |
PS Ratio | 10.87 | 26.55 | 1.10 | 1.51 | 3.72 | 5.12 |